Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. Released May 12, 2015, after the close
10-Q filed May 13, 2015, 43 days after period end · 0001213900-15-003545
Q1 2015 · 10-Q
Revenue—
Net Income-$5.82K-$5.82KN/M vs Q1 2014N/M vs Q4 2014 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
$0.00$0.00— vs Q1 2014no prior Q4 2014 on file Operating Income-$3,962N/M Operating Cash Flow-$1,976N/M Filing lag
ended Mar 31, 2015 · filed May 13, 2015 · 43 d after period end